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1. Introduction
  Bacterial vaginosis (BV) is the most prevalent cause of 
abnormal vaginal discharge among young women at child 
bearing age and has sexual promiscuity as a risk factor[1]. 
It is a gynecologic disorder that is characterized by an 
offensive malodorous thin and homogenous adherent 
discharge in the female lower genital tracts. Otherwise, it is 
colloquially known as “fish odor syndrome”. Those affected 
can suffer from social isolation, depression and attempted 
suicide-reminiscent of the psychosocial symptoms that 
can accompany BV[2]. BV is a clinical condition resulting 
from overgrowth of the vaginal flora. It is characterized by 
reduced number of Lactobacilli and increased presence of 
Gardnerella vaginalis (G. vaginalis), Mycoplasma hominis, 
Mobilincus, Peptostreptococci and Prevotella[3].  
  When left untreated, BV is a possible risk for acquisition 
of HIV/AIDS as well as other complications. Other 
complications include pelvic inflammatory diseases, 
premature rupture of membrane and preterm delivery of 
low birth weight infants. It is now well established that the 
presence of infective vaginal discharge greatly facilitates 
transmission and acquisition of HIV between sexual 
partners[4]. 
  Therefore, prevention, early diagnosis and prompt 
treatment of this common condition especially among the 
risk groups are all important to avert the complications 
and reduce the transmission of HIV. Laboratory support 
is necessary for a differential diagnosis or to confirm the 
clinical diagnosis of bacterial vaginosis.
2. Materials and methods  
2.1. Study area
  The study was done in primary health care (PHC) clinics in 
Jos, Plateau state of Nigeria. Jos has a moderate population 
of about 3.5 million and enjoys a near temperate type of 
climate with attendant tourist activities. There are thriving 
mining activities, brothels, local beer parlors, hotels and 
some higher institutions.
Objective: To determine the prevalence of bacterial vaginosis in the HIV/AIDS patients of 
primary health care clinics in Jos Plateau state, Nigeria. Methods: Female genital swabs were 
collected from primary health care centers, Jos and analyzed by microscopy, culture, etc. in Jos 
University Teaching Hospital from December 2006 to December 2007. Data on epidemiologic 
indices were collected, using structured interviewer-administered questionnaires. Results: 
The incidence of bacterial vaginosis in the study was 28% (n=196/700). Among the HIV/AIDS 
group, the bacterial vaginosis incidence was 36% (n=126/350), while in the control (non-HIV 
patients) group, the rate was 20% (70/350) with a  statistically significant difference at 95 percent 
confidence level (P<0.05) . HIV/AIDS and non-HIV (control) patients contributed 64% (n=126/196) 
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disinfectant/detergent constituted (60%),  poor use of condom 40%, a median age of 26 years, and 
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2.2. Study design
  All patients with abnormal vaginal discharge were screened 
for HIV at the PHC clinics and the positive cases were sent 
for confirmatory test at AIDS Preventive Initiative in Nigeria 
(APIN) laboratory in Jos University Teaching Hospital (JUTH), 
free of charge. Free condoms were given as an incentive. 
Consent of the patients was received and they were recruited 
into the study from December 2006 to December 2007. 
Also, non-HIV (control) group were similarly recruited. 
They were assured of strict confidentiality of responses. 
Structured interviewer-administered questionnaire was then 
introduced. Approval of the study protocol was obtained 
from ethic committee of Jos University Teaching Hospital. 
Further permission was obtained from local government 
councils and the primary health care departments of Jos.
2.3. Laboratory procedure
  High vaginal swabs were collected following aseptic 
precautions[5]. The swabs were immediately sent to the 
genital bench of medical microbiology and parasitology 
laboratory of Jos University Teaching Hospital where they 
were processed according to standard procedures[5]. 
2.3.1. Macroscopy
  Physical examination for the nature, color, consistency 
of the vaginal discharge was done. A characteristic fishy 
odor was intensified by adding a drop of 10% potassium 
hydroxide (KOH) to the vaginal fluid on the examination 
speculum (WHIFF Test). The pH of the vaginal fluid was 
measured by touching the pH indicator paper strips to the 
charged vaginal swabs. The pH generally was elevated to 
more than 4.5. 
2.3.2. Microscopy
  A sample of vaginal fluid from a swab-stick was mixed on 
a glass slide with a drop of normal saline and covered with 
a cover-slip. Ten fields were examined under high power 
(伊40) objective for clue cells (epithelial cells heavily coated 
bacteria sufficient to obscure the cell borders), for motile 
trichomonads and for yeast like cells.
  Vaginal smears were Gram-stained. (a) Microscopic evaluation 
of  Gram-stained smear at high power (伊40) objective revealed 
clue cells, usually representing at least 20 percent of vaginal 
epithelial cells in BV. (b) At oil immersion power (伊100) 
objective, Gram-stain scores of 0-10 were assigned on 
basis of standardized criteria (Nugent), with 0 representing 
Lactobacilli (large Gram-positive rods)predominant 
vaginal flora  while at the extreme 10 representing flora 
predominated by Gardnerella, Bacteroides and Mobilincus 
organisms (small Gram-negative  or variable or curved 
rods). Scores of 0-3 were considered normal, 4-6 borderline 
for BV and 7-10 diagnostic of BV. A score ≥4 was used to 
define abnormal vaginal flora.  
2.3.3. Culture
  High vaginal swab specimens from BV confirmed cases 
were further inoculated on to two sets of enriched blood agar 
media. One set was incubated  aerobically while another set 
was incubated anaerobically, both at temperature of 37 曟
for 24 to 72 hours. Vaginalis agar (V-agar) was inoculated 
and incubated in a similar condition and growth was 
characterized by diffuse hemolysis on human blood single 
layer agar. Similarly, peptone-starch-dextrose agar media 
were inoculated and incubated anaerobically at 37 曟 for 24 
to 72 hours, to observe a growth of tiny colonies, which on 
Gram staining, showed small Gram-negative or variable 
rods. 
  Infection with Candida species was diagnosed by 
microscopy of a saline mount, Gram-stained smear of 
material from the vagina and colonial growth on Sabouraud’s 
Dextrose agar. Trichomonas vaginalis was diagnosed by 
microscopy of a saline mount for the actively motile, spear 
shaped flagellates. The samples collection, transportation 
and processing including microscopy and culture were 
carried out according to recommended standard 5.  
2.4. Statistical analysis
  The results were analysed using SPSS 11.0 statistical 
software; chi-square (χ2) was used to compare association 
between proportions and P-values <0.05 were considered 
significant at 95.0% confidence level. 
3. Result
  One hundred and ninety-six Gardnerella vaginalis 
organisms were detected, constituting 28% of the total 700 
abnormal vaginal discharge specimens (Table 1). Among the 
HIV/AIDS group, the bacterial vaginosis incidence was 36% 
(n=126/350), while in the control (non-HIV patients) group, 
the rate was 20% (70/350) with a  statistically significant 
difference (P<0.05). HIV/AIDS and non-HIV (control) 
patients contributed 64% (n=126/196) and 36% (n=70/196), 
respectively. The baseline demographic characteristics of 
the subjects with BV as recorded are shown in Table 2. The 
risks to bacterial vaginosis included vaginal douching with 
disinfectant/detergent constituted (60%), poor use of condom 
40%, a median age of 26 years, and a median number of 3 
sex partners per week. Three hundred and fifty (50.0%) of 
the 700 patients with abnormal vaginal discharge recruited 
in the study were confirmed HIV reactive by western blot. 
Thirty-six percent (n=126/350) of the HIV/AIDS patients with 
abnormal vaginal discharge were diagnosed of bacterial 
vaginosis, while 20.0% (n=70/350) of non-HIV patients with 
abnormal vaginal discharge had BV.  HIV/AIDS and non-
Table 1 
Distribution of bacterial vaginosis in patients with abnormal vaginal discharge in the primary health care clinics of Jos-Nigeria, December 
2006-December 2007.
Age (years) Abnormal vaginal discharge G. vaginalis G. vaginalis in HIV/AIDS G. vaginalis in non-HIV Other agents of vaginal discharge
  0-10     6   -   - -     6
11-20 173   30   20 10 143
21-30 279   92   59 33 187
31-40 210   57   37 20 153
41-50   30   17   10   7   13
51-60     2   -   - -     2
Total 700 196 126 70 504
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HIV patients contributed 64% (126/196) and 36% (70/196) 
respectively to the total 196 cases of BV. 
 
Table 2 
Demographic characteristics of subjects with BV among the study 
population [%(n)]. 
Variable Proportion 
Contraception none 40% (78)
Condoms alone 25% (49)
Intrauterine device 20% (40)
Oral contraception 10% (20)
Norplant   4% (8)
surgical   1% (2)
<75% condom use 40% (78)
Douching/Vaginal cleansing none 15% (29)
Water alone 25% (49)
Soap/detergent/disinfectant 60% (118)
Place of work brothels 30% (59)
market women 10% (20)
bar 20% (40)
students 10% (20)
food vendors 15% (29)
Others   5% (10)
4. Discussion
  The rate of BV among the general population in the study 
was 28% (n=196/700). Among the HIV/AIDS group in the 
study, the BV rate was 36% (n=126/350) while in the non-HIV 
group was 20.0% (n=70/350). In another study in east Africa, 
the prevalence of BV was 51% among 4 718 rural Ugandan 
women[6]. A similar work in Morocco (north Africa) recorded 
24% of women with vulvo-vaginal or lower abdominal 
complaints attending primary health care clinics[7]. BV 
incidence among pregnant Nigerian women was 17% 
with a 26% peak among the age group of 16 to 20 years[8]. 
In another study in Nigeria, BV was identified to be the 
predictors of HIV[9]. There is strong evidence that the flora 
association with BV increases the acquisition of HIV[4,10]. 
It is independently associated with HIV sero-prevalence. 
HIV infection may promote abnormal vaginal flora or BV 
may increase susceptibility to sexual transmission of HIV. 
Alternatively, this association may result from intervening 
variables. In this case BV may be a marker or a co-factor of 
HIV transmission[10].
  In the study, none use of condom or less than 75% condom 
use contributed 40% risk of BV. Vaginal intercourse 
involving women with three or more sex partners per week 
constituted a high risk. Thirty percent risk was recorded 
among women working in brothels in the study. From the 
findings, it can now be deduced that the presence of semen 
in the vagina allows the abnormal bacteria flora to grow 
more easily[11]. Some cohorts studies found that women 
having exposure to a new sex partner or multiple sex 
partners had an increased incidence of BV[11,12]. Sexually 
active women have vaginal carriage of G. vaginalis more 
often than sexually inexperienced women[12]. All the above 
listed factors are also recorded to promote HIV transmission 
in other notable work[4,13]. Other significant epidemiologic 
factors of BV in the study were as follows: vaginal douching 
with soap/detergent/disinfectant (60%); oral contraception 
(20%); intrauterine device (20%); median age of 26 years. In a 
prospective study, Avonts et al reported a two fold increased 
incidence of BV among intrauterine contraceptive device 
users compared to oral contraceptive users.   
  It is a limitation that quite a number of patients of 
abnormal vaginal discharge refused to be screened for HIV 
in the study because it reduced the population sample.
  We recommend early diagnosis and prompt treatment 
of BV in order to avert the complications and reduce HIV 
transmission.  
  In conclusion, this study shows that the incidence of BV 
is higher in HIV/AIDS group. The vaginal intercourse and 
sexual promiscuity are important risk factors to BV. And 
vaginal douching and intrauterine devices still remain 
notable important epidemiologic factors. 
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